^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
New
Source:
Title:

Therapeutically targetable ALK mutations in leukemia

Excerpt:
GSK1838705A...was also highly potent in inhibiting growth of ALK-transformed cell lines with IC50s of 18 nM and 2nM for the A348D and F856S cells respectively.
DOI:
10.1158%2F0008-5472.CAN-14-1576